Paediatric Clinical Trials Conference

SMi is proud to present the 10th Paediatric Clinical Trials Conference, 16th – 17th March 2016, London. This event will look at the paediatric therapeutic developments, directives and procedures which have been put in place to protect children taking part in clinical trials.
Join us for a series of interactive conference sessions, roundtables and panel discussions facilitated by leading industry experts. Learn how to conduct successful paediatric trials and overcome operational, ethical and legal issues.

Why you should attend?

•    Discuss the framework of US and EU Paediatric Legislation
•    Gain insight into formulation developments and the manufacturing of dry powder inhalation products
•    Evaluate approaches for recruitment and retention
•    Review the challenges in paediatric drug development developing new oncology drugs for children
•    Learn about safety considerations of paediatric clinical trial
To register please get in touch with Matthew Apps on:  +44 20 7827 6093 or e-mail mapps@smi-online.co.uk

KEYNOTE SPEAKERS INCLUDE:

•    Sabine Fuerst-Recktenwald, Senior Medical Director Paediatric Oncology, Roche Pharmaceuticals
•    Ellen Bolotin, Global Clinical Leader in Paediatrics, Bayer
•    Sangeeta Sedani, Clinical Investigation Lead, GSK
•    Albert J. Allen, Senior Medical Fellow, Paediatric Capabilities, Eli Lilly and Company
•    Philippe Auby, Vice President of Global Clinical Research Paediatric Neuro-Psychiatry, Lundbeck SAS
•    Ronald Rosenburg, Senior International Clinical Lead, Grunenthal
•    Kristina An Haack, Clinical Study Director, Sanofi

PLUS A FULL DAY INTERACTIVE PRE-CONFERENCE WORKSHOP
Tuesday 15th March 2016, Holiday Inn Kensington Forum, London, UK
Drug development in the paediatric population
Workshop Leader: Klaus Rose, CEO, Klausrose Consulting